Admedus" CardioCell biomaterial scaffold technology validated by independent peer-reviewed study - Proactive Investors Australia

Admedus" CardioCell biomaterial scaffold technology validated by independent peer-reviewed study  Proactive Investors Australia

Admedus Ltd (ASX:AHZ) has had its CardioCel transcatheter aortic valve replacement (TAVR) devices validated through the publication of an independent study ...



Comments

Popular posts from this blog

Different types of doctors in South Africa and their salaries 2022 - Briefly

Your Covid booster side effects shouldn't be as 'intense' this time — here's what to expect - CNBC

Ebstein's Anomaly: Symptoms, Causes, and Treatments - Verywell Health